Expert Insight

Quality. Passion. Knowledge.

ApiJect experts share knowledge and know-how to deliver innovative solutions customized to achieve our customer's goals and objectives.

The ApiJect Story

The ApiJect Story
ApiJect’s Origin: The Marc Koska Story
ApiJect Company Profile

Published Articles

The global vaccine effort will be a hollow victory if it leads to unsafe injection practices, Washington Post
NPR speaks with ApiJect’s Ed Kelley, PhD: “A Looming Challenge In The Vaccination Campaign: Syringe Shortages”
Pharmaceutical Technology Webinar Follow-up Part 3: Single-Dose Drug Delivery Fill-Finish Facility that is Scalable, Flexible, and able to Delivery up to 45M units Per Month, Delivered within an Accelerated Timeline of Fewer Than 7 Months
Pharmaceutical Technology Webinar Follow-up Part 2: Solving Drug Challenges with Innovation, BFS, and a Technology Platform to Create Drug Delivery Systems
Pharmaceutical Technology Webinar Follow-up Part 1: Blow-Fill-Seal & Prefilled Syringes: A Solution for complex Formulations
SPECIAL FEATURE – PFS & Parenteral Manufacturing: How COVID-19 Changed the Market

Data Sheets

Partnering: Pharmaceutical Companies
Blow-Fill-Seal
Procurement and Supply Chain
BFS Temperature Management

Industry Insights

Ray_Sell_Insights
Blow-Fill-Seal (BFS) Covers Injectables and Vaccines, Too
How We Beat the Heat in Blow-Fill-Seal
The Heat Factor: Why it Matters in Blow-Fill-Seal
Prefilled Syringes: Why I am an Optimist
Prefilled Syringes: Yes, There are a Few Challenges
Prefilled Syringes: Rapid Growth Expected to Continue

Global Publications

Injection Technology for Vaccines and Medicines: Past Evolution, Future Landscape

Video

Ed Kelley, PhD was interviewed by the Australian Broadcasting Corporation (ABC)

Webinars

As global demand for PFS continues to increase, a new format is emerging that utilizes BFS technology to meet the demand and provide a cost-effective and safe way to deliver injectables to patients around the world. Advances in aseptic BFS have enabled an increasingly wide range of large molecules to be successfully filled and finished using BFS technology, making it suitable and qualified to handle most drug products. The reliability of BFS PFS and the availability of its materials in major markets offers companies a flexible, reliable, and robust supply chain even in challenging global environments. View this webcast on-demand any time.

Discover our story and the passion that drives us.

Companies don’t improve the world. People do. See the leaders who drive ApiJect to fulfill our mission.

See Our Leaders